219 Long-term clinical outcomes associated with sequential treatment of BRAF mutant advanced melanoma patients

• David McDermott,
• Michael Atkins,
• Ahmad Tarhini,
• Apoorva Ambavane,
• Agnes Benedict,
• Cho-Han Lee,
• Corey Ritchings,
• Brian Stwalley,
• Meredith Regan

Affiliations

David McDermott

2Harvard Medical School; Beth Israel Deaconess Medical Center, Boston, MA, USA

Michael Atkins

6Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA

Ahmad Tarhini

1Moffitt Comprehensive Cancer Center and Research Institute, Tampa, FL, USA

Apoorva Ambavane

3Evidera, London, MD, UK

Agnes Benedict

3Evidera, London, MD, UK

Cho-Han Lee

4Bristol Myers Squibb, Princeton, NJ, USA

Corey Ritchings

4Bristol Myers Squibb, Princeton, NJ, USA

Brian Stwalley

4Bristol Myers Squibb, Princeton, NJ, USA

Meredith Regan

5Harvard Medical School and Dana-Farber Cancer Institute, Boston, MA, USA